Brief: VANC Pharmaceuticals signs agreement for exclusive in-license on generic molecule
20/06/2016 13:00
June 20 (Reuters) - VANC Pharmaceuticals NPH.V :
* VANC Pharmaceuticals signs definitive agreement for
exclusive in license on a C$150m generic molecule and soon to be
off patent molecule
* Says entered into definitive agreement for filing two ands
with exclusive marketing rights to Canada from an unnamed
manufacturer
* Says other product will become off patent in 2017
Source text for Eikon: ID:nMKWND6wpa
Further company coverage: NPH.V
((Bengaluru Newsroom: +1-646-223-8780))